Bayer and Iambic collaborate to advance drug discovery with AI
Iambic official newsroom · 行業原文收錄 · 來源發佈：Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:08:35 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
Bayer and Iambic collaborate to advance drug discovery with AI Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research and development portfolio by harnessing AI to accelerate drug discovery Berlin, Germany and San Diego, USA, June 22, 2026 – Bayer and Iambic Therapeutics Inc., a clinica
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。